Registration
STEPTOE LLP for OREXO US, INC.
Firm
Client
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Alcohol and Drug Abuse ALC
Advocacy on xylazine and adultered-opioid overdose solutions and federal funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LESLIE BELCHER New | — |
| ROWAN BOST New | Legislative Aide, Office of Senator Susan Collins; Legislative Correspondent, Office of Senator Susan Collins; Intern, Office of Senator Susan Collins; Senate Page, Senator Olympia Snowe |
| MATTHEW FLYNN New | Mbr-HSAC; Dep Asst Sec Def-DOD; Couns, L&M Mgmt-DOI; Dep Asst to the Pres & Acting WH Cabinet Sec., Dep Cabinet Sec., Special Asst to the Pres, Sr. Dir. for Cabinet Affairs-EOP; Sr Adv.-State; LC/Dep Health Counsel, Intern-House |
Budget/Appropriations BUD
Advocacy on xylazine and adultered-opioid overdose solutions and federal funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LESLIE BELCHER New | — |
| ROWAN BOST New | Legislative Aide, Office of Senator Susan Collins; Legislative Correspondent, Office of Senator Susan Collins; Intern, Office of Senator Susan Collins; Senate Page, Senator Olympia Snowe |
| MATTHEW FLYNN New | Mbr-HSAC; Dep Asst Sec Def-DOD; Couns, L&M Mgmt-DOI; Dep Asst to the Pres & Acting WH Cabinet Sec., Dep Cabinet Sec., Special Asst to the Pres, Sr. Dir. for Cabinet Affairs-EOP; Sr Adv.-State; LC/Dep Health Counsel, Intern-House |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| OREXO AB | Switzerland | Switzerland | 100.0% | — |
Affiliated organisations
| Organisation | Location |
|---|---|
| OREXO AB | Uppsala, CH |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.